In the Hot Seat at ACC: PE Clot-Buster, Impella-Protected PCI, Utility of CAC=0

(MedPage Today) — NEW ORLEANS — This weekend, catheter-based therapies have potentially practice-changing trial results expected at the American College of Cardiology (ACC) annual conference.
Kicking off the opening late-breaking clinical…

Source link : https://www.medpagetoday.com/meetingcoverage/acc/120506

Author :

Publish date : 2026-03-26 18:22:00

Copyright for syndicated content belongs to the linked Source.

M	T	W	T	F	S	S
1	2	3	4	5	6	7
8	9	10	11	12	13	14
15	16	17	18	19	20	21
22	23	24	25	26	27	28
29	30

In the Hot Seat at ACC: PE Clot-Buster, Impella-Protected PCI, Utility of CAC=0

Dupilumab May Simplify Chronic Spontaneous Urticaria Treatment

Here’s What People Want on ‘The Pitt’ Season 3

Related Posts

Advanced radiotherapy for prostate cancer to cut sessions from 20 to five

Dementia May Be Worse for People Taking Popular Supplement

Kids’ Risk of Severe Respiratory Infection Rises With Comorbidity Count

First Guideline on Cardiovascular-Kidney-Metabolic Syndrome Released

ACC/AHA Release First-Ever Guideline for CKM Syndrome

Stem Cell Transplant for Sickle Cell Disease More Cost-Effective Than Gene Therapy

Advanced radiotherapy for prostate cancer to cut sessions from 20 to five

Dementia May Be Worse for People Taking Popular Supplement

Kids’ Risk of Severe Respiratory Infection Rises With Comorbidity Count

First Guideline on Cardiovascular-Kidney-Metabolic Syndrome Released

ACC/AHA Release First-Ever Guideline for CKM Syndrome

Stem Cell Transplant for Sickle Cell Disease More Cost-Effective Than Gene Therapy

Oral Small-Molecule Elecoglipron Tackles Obesity and Diabetes

FDA Approves First New Sunscreen Option in Two Decades

Categories

Archives